IL7 and acute graft versus host disease: Specifically, the 180-day cumulative incidence of grade II–IV acute GVHD was 29% in patients with day 7 IL-7 levels>median (5.1 pg/mL) versus 20% in patients with day 7 IL-7 levels ≤ median (P = 0.38) (Figure 3A).